Spanish Red Biotech Pipeline

Amgen

carfilzomib

Type: Biodrugs/ Drugs
Therapeutic area: Cancer
Dermatology
Indication: Relapsed or refractory multiple myeloma
Phase: 3Phase III in Spain, 2Phase II, 1Phase I